Evolent Health, Inc.
US ˙ NYSE ˙ US30050B1017

SecurityEVH / Evolent Health, Inc.
InstitutionSei Investments Co
Latest Disclosed Ownership200,414 shares
Latest Disclosed Value $ 801,606
Sei Investments Co reports 62.28% increase in ownership of EVH / Evolent Health, Inc.

On February 13, 2026 - Sei Investments Co filed a 13F-HR form disclosing ownership of 200,414 shares of Evolent Health, Inc. (US:EVH) valued at $801,656 USD as of December 31, 2025. The entity filed a previous 13F-HR on November 13, 2025 disclosing 123,501 shares of Evolent Health, Inc.. This represents a change in shares of 62.28% during the quarter. The current value of the position is $757,565 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-02-13 2025-12-31 13F EVOLENT HEALTH CL A 30050B101 200,414 76,913 62.28 802 -23.28 0.0008
2025-11-13 2025-09-30 13F EVOLENT HEALTH CL A 30050B101 123,501 19,313 18.54 1,045 -11.00 0.0011
2025-08-14 2025-06-30 13F EVOLENT HEALTH CL A 30050B101 104,188 9,919 10.52 1,173 31.50 0.0014
2025-05-14 2025-03-31 13F/A-1 EVOLENT HEALTH CL A 30050B101 94,269 -30,034 -24.16 893 -36.19 0.0011
2025-05-13 2025-03-31 13F EVOLENT HEALTH CL A 30050B101 125,823 1,520 1,399 0.0015
2025-02-11 2024-12-31 13F EVOLENT HEALTH CL A 30050B101 124,303 -2,115 -1.67 1,398 -60.90 0.0018
2024-11-12 2024-09-30 13F EVOLENT HEALTH CL A 30050B101 126,418 37,364 41.96 3,575 110.05 0.0046
2024-08-13 2024-06-30 13F EVOLENT HEALTH CL A 30050B101 89,054 -20,315 -18.57 1,703 -52.54 0.0024
2024-05-07 2024-03-31 13F EVOLENT HEALTH CL A 30050B101 109,369 -613 -0.56 3,586 -1.27 0.0053
2024-02-14 2023-12-31 13F EVOLENT HEALTH CL A 30050B101 109,982 3,800 3.58 3,633 25.63 0.0058
2023-11-14 2023-09-30 13F EVOLENT HEALTH CL A 30050B101 106,182 -84,186 -44.22 2,891 -49.87 0.0052
2023-08-11 2023-06-30 13F EVOLENT HEALTH CL A 30050B101 190,368 -33,700 -15.04 5,768 -20.68 0.0101
2023-05-12 2023-03-31 13F EVOLENT HEALTH CL A 30050B101 224,068 129,045 135.80 7,271 172.53 0.0135
2023-02-10 2022-12-31 13F EVOLENT HEALTH CL A 30050B101 95,023 -103,532 -52.14 2,668 -62.60 0.0059
2022-11-14 2022-09-30 13F EVOLENT HEALTH CL A 30050B101 198,555 136,793 221.48 7,134 276.07 0.0159
2022-08-15 2022-06-30 13F EVOLENT HEALTH CL A 30050B101 61,762 1,605 2.67 1,897 -2.37 0.0041
2022-05-13 2022-03-31 13F EVOLENT HEALTH CL A 30050B101 60,157 -5,268 -8.05 1,943 7.35 0.0039
2022-02-14 2021-12-31 13F EVOLENT HEALTH CL A 30050B101 65,425 -519 -0.79 1,810 -11.53 0.0034
2021-11-12 2021-09-30 13F EVOLENT HEALTH CL A 30050B101 65,944 -9,829 -12.97 2,046 28.84 0.0043
2021-08-06 2021-06-30 13F EVOLENT HEALTH CL A 30050B101 75,773 -959 -1.25 1,588 8.69 0.0035
2021-05-12 2021-03-31 13F EVOLENT HEALTH CL A 30050B101 76,732 -1,081 -1.39 1,461 15.49 0.0037
2021-02-08 2020-12-31 13F EVOLENT HEALTH CL A 30050B101 77,813 -64,726 -45.41 1,265 -30.26 0.0033
2020-12-04 2020-09-30 13F/A-1 EVOLENT HEALTH CL A 30050B101 142,539 78,695 123.26 1,814 298.68 0.0053
2020-11-06 2020-09-30 13F EVOLENT HEALTH CL A 30050B101 169,331 105,487 2,146 5,167.0909
2020-08-17 2020-06-30 13F/A-1 EVOLENT HEALTH CL A 30050B101 63,844 -56,109 -46.78 455 -30.21 0.0014
2020-08-11 2020-06-30 13F EVOLENT HEALTH CL A 30050B101 139,155 19,202 1,259 3,415.1045
2020-05-14 2020-03-31 13F EVOLENT HEALTH CL A 30050B101 119,953 -19,098 -13.73 652 -48.17 0.0024
2020-02-06 2019-12-31 13F EVOLENT HEALTH CL A 30050B101 139,051 -17,683 -11.28 1,258 11.62 0.0038
2019-11-12 2019-09-30 13F EVOLENT HEALTH CL A 30050B101 156,734 9,432 6.40 1,127 -3.76 0.0029
2019-08-14 2019-06-30 13F EVOLENT HEALTH CL A 30050B101 147,302 114,501 349.08 1,171 183.54 0.0038
2019-05-15 2019-03-31 13F EVOLENT HEALTH CL A 30050B101 32,801 7,254 28.39 413 -43.11 0.0014
2019-02-13 2018-12-31 13F EVOLENT HEALTH CL A 30050B101 25,547 0 0.00 726 0.00 0.0026
2018-11-08 2018-09-30 13F EVOLENT HEALTH CL A 30050B101 25,547 25,547 726 0.0026
2017-11-06 2017-09-30 13F EVOLENT HEALTH CL A 30050B101 0 -26,055 -100.00 0 -100.00
2017-07-31 2017-06-30 13F EVOLENT HEALTH CL A 30050B101 26,055 26,055 660 0.0026
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.